170 filings
Page 2 of 9
SC TO-C
pybvv5902 t90slpwv
12 Jul 16
Information about tender offer
12:00am
SC14D9C
wtb4spthq6v6pdln ae
12 Jul 16
Written communication relating to third party tender offer
12:00am
SC14D9C
y910859ikisx9wh
11 Jul 16
Written communication relating to third party tender offer
12:00am
SC TO-C
nvab5kxmxtd7bs
11 Jul 16
Information about tender offer
12:00am
8-K
lit9gxfcsb2vt4
11 Jul 16
Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals
12:00am
SC14D9C
7kmoosnm4ah04m
11 Jul 16
Written communication relating to third party tender offer
12:00am
SC TO-C
9470 uxx45
11 Jul 16
Information about tender offer
12:00am
8-K
k5r9mt8rywmy8
22 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
oa6ksyjr
16 Jun 16
Sagent Pharmaceuticals Acquires Product Portfolio
12:00am
8-K
vlq hqsri5og70
10 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
bjqbx3o5
13 May 16
Departure of Directors or Certain Officers
12:00am
8-K
2uwvtb70pny
3 May 16
Sagent Pharmaceuticals Reports First Quarter 2016 Financial Results
12:00am
8-K
bo3zt5ugeukoyaq su7v
6 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
8joqr9kydqqgvd8gl
28 Mar 16
Results of Operations and Financial Condition
12:00am
8-K
ebmxi44s4 p6sl6h78vc
23 Mar 16
Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
12:00am
8-K
sgb2gw
25 Feb 16
Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
12:00am
8-K
tk01d6i 3x
16 Feb 16
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results
12:00am